Yarger Wealth Strategies LLC Purchases New Position in Synopsys, Inc. $SNPS

Yarger Wealth Strategies LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 797 shares of the semiconductor company’s stock, valued at approximately $409,000.

A number of other hedge funds also recently bought and sold shares of SNPS. Cornerstone Planning Group LLC increased its holdings in Synopsys by 275.0% during the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 44 shares during the period. Saudi Central Bank bought a new position in Synopsys in the first quarter worth about $26,000. Clal Insurance Enterprises Holdings Ltd raised its stake in Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after buying an additional 53 shares in the last quarter. Independence Bank of Kentucky raised its stake in Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares in the last quarter. Finally, WPG Advisers LLC bought a new position in Synopsys in the first quarter worth about $34,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In other news, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the sale, the chief financial officer owned 15,317 shares in the company, valued at $9,339,847.09. This represents a 19.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the sale, the chief executive officer owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 over the last three months. Company insiders own 0.62% of the company’s stock.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $438.92 on Monday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a 50 day simple moving average of $544.01 and a two-hundred day simple moving average of $510.99. The company has a market capitalization of $81.53 billion, a price-to-earnings ratio of 34.45, a P/E/G ratio of 4.84 and a beta of 1.10. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the prior year, the business posted $3.43 EPS. Synopsys’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Analysts Set New Price Targets

SNPS has been the subject of a number of research reports. Piper Sandler decreased their price target on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research note on Wednesday, September 10th. Morgan Stanley decreased their price target on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a research note on Thursday, September 11th. Zacks Research downgraded shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Friday, September 12th. Needham & Company LLC decreased their price target on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Wall Street Zen downgraded shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Eleven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $575.31.

Check Out Our Latest Report on SNPS

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.